Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
de Bono, Johann Sebastian, Dr, Oudard, Stephane, MD, Ozguroglu, Mustafa, MD, Hansen, Steinbjørn, MD, Machiels, Jean-Pascal, MD, Kocak, Ivo, MD, Gravis, Gwenaëlle, MD, Bodrogi, Istvan, MD, Mackenzie, Mary J, MD, Shen, Liji, PhD, Roessner, Martin, MS, Gupta, Sunil, MD, Sartor, A Oliver, MD
Published in The Lancet (British edition) (02.10.2010)
Published in The Lancet (British edition) (02.10.2010)
Get full text
Journal Article